U.S. funded biological labs abroad

Reports of Biolabs before the NATO war in Ukraine

Back in 2020, CGTN discussed US biolabs around the world.

Republic of Georgia

The Lugar Center Biological Weapons Research Laboratory in Georgia owned and operated by the U.S. Department of Defense.

The regional headquarters of the U.S. Department of Defense's for the central Eurasian biological weapons labs, including those for Ukraine, are located on the Russian border at The Lugar Center, just outside the capital of Tbilisi in the Republic of Georgia.

In 2007 Georgia ended its policy of having compulsory annual livestock anthrax vaccination. As a result, the morbidity rate of the disease reached its peak in 2013. The same year NATO started human based anthrax vaccine tests at the Lugar Center in Georgia.

In 2007 despite the anthrax outbreak the Georgian government terminated the compulsory vaccination for 7 years, 2013 saw NATO start human trials on a new anthrax vaccine in Georgia.

Anthrax is one of the bio agents weaponized by the US Army in the past. Despite the Pentagon’s claims that its program is only defensive, there are facts to the contrary. In 2016 at the Lugar Center American scientists carried out research on the “Genome Sequence of the Soviet/Russian Bacillus anthracis Vaccine Strain 55-VNIIVViM”, which was funded by DTRA's Cooperative Biological Engagement Program and administered by Metabiota. In 2017 the DTRA funded further research – Ten Genome Sequences of Human and Livestock Isolates of Bacillus anthracis from the Country of Georgia, which was performed by USAMRU-G at The Lugar Center.

Crimean-Congo hemorrhagic fever (CCHF) is caused by infection through a tick-borne virus (Nairovirus). The disease was first characterized in Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in Congo, thus resulting in the current name of the disease. In 2014 34 people became infected (among them a 4-year old child) with CCHF, 3 of which died. The same year Pentagon biologists studied the virus in Georgia under the DTRA project “Epidemiology of febrile illnesses caused by Dengue viruses and other Arboviruses in Georgia”. The project included tests on patients with fever symptoms and the collection of ticks, as possible vectors of CCHV for laboratory analysis.

The cause of the CCHF outbreak in Georgia is still unknown. According to the local Veterinary Department report, only one tick from all of the collected species from the infected villages tested positive for the disease. Despite the claims of the local authorities that the virus was transmitted to humans from animals, all animal blood samples were negative too. The lack of infected ticks and animals is inexplicable given the sharp increase of CCHF human cases in 2014, meaning that the outbreak was not natural and the virus was spread intentionally.

In 2016 another 21,590 ticks were collected for DNA database for future studies at The Lugar Center under the Pentagon project “Assessing the Seroprevalence and Genetic Diversity of Crimean-Congo Hemorrhagic Fever Virus (CCHFV) and Hantaviruses in Georgia”.

While Finland and Sweden's applications to join NATO were fast-tracked, the Republic of Georgia has been waiting for 15 years. Georgia's membership was not on the agenda for NATO's June 2022 summit. 10,000 Russian troops are in the former Georgian territories of Abkhazia and South Ossetia. NATO's discriminatory behavior led to growing anti-NATO sentiment in Georgia.

Ukraine

Russian military reported it had identified 30 sites where biological research with pathogens had been occurring under the direction of the Pentagon; Victoria Nuland later confirmed 46 locations.

Ukraine has no control over the military bio-laboratories on its own territory. According to the 2005 Agreement between the US DoD and the Ministry of Health of Ukraine the Ukrainian government is prohibited from public disclosure of sensitive information about the US program and Ukraine is obliged to transfer to the US Department of Defense (DoD) dangerous pathogens for biological research. The Pentagon has been granted access to certain state secrets of Ukraine in connection with the projects under their agreement.

Only three laboratories in Ukraine had the required safety criteria to undertake the type of research they were doing, according to the Russian military. Captured Ukrainian government documents point to a series of problems at one of those sites in Odessa.

Lieutenant General Igor Kirillov, the head of the Radioactive, Chemical, and Biological Protection Forces, accused the Kyiv regime of carrying out “inhumane experiments” on Ukrainian patients and of launching a biological attack against the Lugansk Peoples Republic in early May 2022. Other evidence suggests that when Russia moved soldiers into Ukraine in February 2022, attempts were made to weaponize drones to spread pathogens and to destroy compromising materials. In response to the revelations by Russia’s Investigative Committee, the Pentagon fessed up in June 2022 to funding 46 biological research facilities in Ukraine over the last 20 years.

Pfizer experimental covid vaccine was reportedly tested on military personnel and civilians.

DTRA

The DoD Defense Threat Reduction Agency (DTRA) has funded 11 bio-laboratories in Ukraine. The official documents confirm that the Pentagon, represented by the US Defense Threat Reduction Agency (DTRA), is organising work with a clear military-biological focus.

𝘛𝘩𝘦 𝘥𝘰𝘤𝘶𝘮𝘦𝘯𝘵 𝘯𝘰𝘵𝘦𝘴 𝘵𝘩𝘦 𝘯𝘦𝘦𝘥 𝘵𝘰 𝘵𝘳𝘢𝘯𝘴𝘧𝘦𝘳 𝘢𝘭𝘭 𝘤𝘰𝘭𝘭𝘦𝘤𝘵𝘪𝘰𝘯𝘴 𝘰𝘧 𝘩𝘪𝘨𝘩𝘭𝘺 𝘥𝘢𝘯𝘨𝘦𝘳𝘰𝘶𝘴 𝘱𝘢𝘵𝘩𝘰𝘨𝘦𝘯𝘴 𝘵𝘰 𝘢 𝘤𝘦𝘯𝘵𝘳𝘢𝘭 𝘳𝘦𝘧𝘦𝘳𝘦𝘯𝘤𝘦 𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘰𝘳𝘺 𝘪𝘯 𝘰𝘳𝘥𝘦𝘳 𝘵𝘰 𝘧𝘢𝘤𝘪𝘭𝘪𝘵𝘢𝘵𝘦 𝘵𝘩𝘦𝘪𝘳 𝘰𝘳𝘥𝘦𝘳𝘭𝘺 𝘦𝘹𝘱𝘰𝘳𝘵 𝘵𝘰 𝘵𝘩𝘦 𝘜𝘚𝘈… 𝘵𝘩𝘦 𝘜𝘚 𝘩𝘢𝘯𝘥𝘭𝘦𝘳𝘴 𝘥𝘦𝘮𝘢𝘯𝘥𝘦𝘥 … 𝘢𝘭𝘭 𝘷𝘪𝘰𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘰𝘤𝘤𝘶𝘳𝘳𝘦𝘥 𝘥𝘶𝘳𝘪𝘯𝘨 𝘵𝘩𝘦 𝘱𝘦𝘳𝘪𝘰𝘥 𝘰𝘧 𝘵𝘩𝘦 𝘜𝘚 𝘣𝘪𝘰-𝘵𝘩𝘳𝘦𝘢𝘵 𝘳𝘦𝘥𝘶𝘤𝘵𝘪𝘰𝘯 𝘱𝘳𝘰𝘨𝘳𝘢𝘮𝘮𝘦. 𝘛𝘩𝘪𝘴 𝘥𝘦𝘮𝘰𝘯𝘴𝘵𝘳𝘢𝘵𝘦𝘴 𝘵𝘩𝘢𝘵 𝘞𝘢𝘴𝘩𝘪𝘯𝘨𝘵𝘰𝘯’𝘴 𝘰𝘧𝘧𝘪𝘤𝘪𝘢𝘭𝘭𝘺 𝘥𝘦𝘤𝘭𝘢𝘳𝘦𝘥 𝘨𝘰𝘢𝘭𝘴 𝘢𝘳𝘦 𝘮𝘦𝘳𝘦𝘭𝘺 𝘢 𝘴𝘤𝘳𝘦𝘦𝘯 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘪𝘮𝘱𝘭𝘦𝘮𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘪𝘭𝘭𝘦𝘨𝘢𝘭 𝘮𝘪𝘭𝘪𝘵𝘢𝘳𝘺-𝘣𝘪𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘢𝘤𝘵𝘪𝘷𝘪𝘵𝘪𝘦𝘴 𝘪𝘯 𝘜𝘬𝘳𝘢𝘪𝘯𝘦. 𝘍𝘰𝘳 𝘦𝘹𝘢𝘮𝘱𝘭𝘦, 𝘸𝘰𝘳𝘬 𝘸𝘪𝘵𝘩 𝘥𝘢𝘯𝘨𝘦𝘳𝘰𝘶𝘴 𝘱𝘢𝘵𝘩𝘰𝘨𝘦𝘯𝘴 𝘶𝘯𝘥𝘦𝘳 𝘗𝘦𝘯𝘵𝘢𝘨𝘰𝘯 𝘤𝘰𝘯𝘵𝘳𝘰𝘭 𝘪𝘯 𝘒𝘩𝘢𝘳𝘬𝘰𝘷, 𝘒𝘪𝘦𝘷 𝘢𝘯𝘥 𝘢 𝘯𝘶𝘮𝘣𝘦𝘳 𝘰𝘧 𝘰𝘵𝘩𝘦𝘳 𝘤𝘪𝘵𝘪𝘦𝘴 𝘸𝘢𝘴 𝘤𝘢𝘳𝘳𝘪𝘦𝘥 𝘰𝘶𝘵 𝘪𝘯 𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘰𝘳𝘪𝘦𝘴 𝘸𝘪𝘵𝘩 𝘪𝘯𝘴𝘶𝘧𝘧𝘪𝘤𝘪𝘦𝘯𝘵 𝘴𝘵𝘢𝘧𝘧 𝘱𝘳𝘰𝘵𝘦𝘤𝘵𝘪𝘰𝘯.. 𝘛𝘩𝘦 𝘚𝘦𝘤𝘶𝘳𝘪𝘵𝘺 𝘚𝘦𝘳𝘷𝘪𝘤𝘦 𝘰𝘧 𝘜𝘬𝘳𝘢𝘪𝘯𝘦 𝘯𝘰𝘵𝘦𝘥 𝘵𝘩𝘦 𝘱𝘳𝘦𝘤𝘰𝘯𝘥𝘪𝘵𝘪𝘰𝘯𝘴 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘦𝘮𝘦𝘳𝘨𝘦𝘯𝘤𝘦 𝘰𝘧 𝘣𝘪𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘵𝘩𝘳𝘦𝘢𝘵𝘴 𝘥𝘶𝘦 𝘵𝘰 𝘴𝘺𝘴𝘵𝘦𝘮𝘢𝘵𝘪𝘤 𝘷𝘪𝘰𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘢𝘯𝘥 𝘱𝘰𝘰𝘳 𝘲𝘶𝘢𝘭𝘪𝘵𝘺 𝘰𝘧 𝘸𝘰𝘳𝘬 𝘪𝘯 𝘵𝘩𝘦 𝘳𝘦𝘤𝘰𝘯𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘰𝘯 𝘰𝘧 𝘣𝘪𝘰𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘰𝘳𝘪𝘦𝘴.. 𝘛𝘩𝘦 𝘧𝘢𝘤𝘪𝘭𝘪𝘵𝘺 𝘸𝘢𝘴 𝘤𝘰𝘮𝘮𝘪𝘴𝘴𝘪𝘰𝘯𝘦𝘥 𝘪𝘯 𝘤𝘪𝘳𝘤𝘶𝘮𝘷𝘦𝘯𝘵𝘪𝘰𝘯 𝘰𝘧 𝘣𝘪𝘰𝘴𝘢𝘧𝘦𝘵𝘺 𝘳𝘦𝘨𝘶𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘢𝘯𝘥 𝘳𝘦𝘲𝘶𝘪𝘳𝘦𝘮𝘦𝘯𝘵𝘴.. 𝘵𝘩𝘦 𝘳𝘦𝘱𝘰𝘳𝘵 𝘴𝘩𝘰𝘸𝘴 𝘨𝘳𝘰𝘴𝘴 𝘷𝘪𝘰𝘭𝘢𝘵𝘪𝘰𝘯𝘴 𝘰𝘧 𝘴𝘵𝘰𝘳𝘢𝘨𝘦 𝘤𝘰𝘯𝘥𝘪𝘵𝘪𝘰𝘯𝘴 𝘧𝘰𝘳 𝘮𝘪𝘤𝘳𝘰-𝘰𝘳𝘨𝘢𝘯𝘪𝘴𝘮𝘴, 𝘭𝘢𝘤𝘬 𝘰𝘧 𝘢𝘤𝘤𝘦𝘴𝘴 𝘤𝘰𝘯𝘵𝘳𝘰𝘭 𝘢𝘯𝘥 𝘮𝘢𝘯𝘢𝘨𝘦𝘮𝘦𝘯𝘵 𝘴𝘺𝘴𝘵𝘦𝘮𝘴 𝘢𝘯𝘥 𝘪𝘯𝘢𝘥𝘦𝘲𝘶𝘢𝘵𝘦 𝘷𝘦𝘯𝘵𝘪𝘭𝘢𝘵𝘪𝘰𝘯 𝘴𝘺𝘴𝘵𝘦𝘮𝘴.. 𝘐𝘯 𝘈𝘱𝘳𝘪𝘭 2017, 𝘵𝘩𝘦𝘳𝘦 𝘸𝘢𝘴 𝘢 𝘤𝘢𝘴𝘦 𝘰𝘧 𝘪𝘯𝘵𝘦𝘳𝘯𝘢𝘭 𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘰𝘳𝘺 𝘪𝘯𝘧𝘦𝘤𝘵𝘪𝘰𝘯 𝘸𝘪𝘵𝘩 𝘵𝘪𝘤𝘬-𝘣𝘰𝘳𝘯𝘦 𝘦𝘯𝘤𝘦𝘱𝘩𝘢𝘭𝘪𝘵𝘪𝘴 𝘪𝘯 𝘰𝘯𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘪𝘯𝘴𝘵𝘪𝘵𝘶𝘵𝘦’𝘴 𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘰𝘳𝘪𝘦𝘴 𝘢𝘴 𝘢 𝘳𝘦𝘴𝘶𝘭𝘵 𝘰𝘧 𝘢 𝘴𝘢𝘧𝘦𝘵𝘺 𝘷𝘪𝘰𝘭𝘢𝘵𝘪𝘰𝘯. 𝘛𝘩𝘦 𝘣𝘢𝘤𝘬𝘣𝘰𝘯𝘦 𝘰𝘧 𝘵𝘩𝘪𝘴 𝘯𝘦𝘵𝘸𝘰𝘳𝘬, 𝘸𝘩𝘪𝘤𝘩 𝘩𝘢𝘴 𝘣𝘦𝘦𝘯 𝘧𝘰𝘳𝘮𝘦𝘥 𝘣𝘺 𝘵𝘩𝘦 𝘗𝘦𝘯𝘵𝘢𝘨𝘰𝘯 𝘴𝘪𝘯𝘤𝘦 1997, 𝘪𝘴 𝘵𝘩𝘦 𝘞𝘢𝘭𝘵𝘦𝘳 𝘙𝘦𝘦𝘥 𝘈𝘳𝘮𝘺 𝘐𝘯𝘴𝘵𝘪𝘵𝘶𝘵𝘦 𝘰𝘧 𝘙𝘦𝘴𝘦𝘢𝘳𝘤𝘩 (𝘔𝘢𝘳𝘺𝘭𝘢𝘯𝘥). 𝘐𝘵 𝘪𝘯𝘤𝘭𝘶𝘥𝘦𝘴 𝘭𝘢𝘯𝘥 𝘢𝘯𝘥 𝘯𝘢𝘷𝘢𝘭 𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘰𝘳𝘪𝘦𝘴 𝘢𝘴 𝘸𝘦𝘭𝘭 𝘢𝘴 𝘮𝘪𝘭𝘪𝘵𝘢𝘳𝘺 𝘣𝘢𝘴𝘦𝘴 𝘢𝘳𝘰𝘶𝘯𝘥 𝘵𝘩𝘦 𝘸𝘰𝘳𝘭𝘥.. 𝘵𝘩𝘦 𝘥𝘦𝘴𝘵𝘳𝘶𝘤𝘵𝘪𝘷𝘦 𝘪𝘯𝘧𝘭𝘶𝘦𝘯𝘤𝘦 𝘰𝘧 𝘜𝘚 𝘩𝘢𝘯𝘥𝘭𝘦𝘳𝘴 𝘱𝘰𝘴𝘦 𝘢 𝘥𝘪𝘳𝘦𝘤𝘵 𝘵𝘩𝘳𝘦𝘢𝘵 𝘵𝘰 𝘜𝘬𝘳𝘢𝘪𝘯𝘪𝘢𝘯 𝘢𝘯𝘥 𝘌𝘶𝘳𝘰𝘱𝘦𝘢𝘯 𝘤𝘪𝘷𝘪𝘭𝘪𝘢𝘯𝘴.. 𝘵𝘩𝘦 𝘞𝘦𝘴𝘵 𝘈𝘧𝘳𝘪𝘤𝘢𝘯 𝘴𝘵𝘳𝘢𝘪𝘯 𝘰𝘧 𝘮𝘰𝘯𝘬𝘦𝘺𝘱𝘰𝘹 𝘰𝘳𝘪𝘨𝘪𝘯𝘢𝘵𝘦𝘥 𝘪𝘯 𝘕𝘪𝘨𝘦𝘳𝘪𝘢, 𝘢𝘯𝘰𝘵𝘩𝘦𝘳 𝘴𝘵𝘢𝘵𝘦 𝘪𝘯 𝘸𝘩𝘪𝘤𝘩 𝘵𝘩𝘦 𝘜𝘚 𝘩𝘢𝘴 𝘥𝘦𝘱𝘭𝘰𝘺𝘦𝘥 𝘪𝘵𝘴 𝘣𝘪𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭 𝘪𝘯𝘧𝘳𝘢𝘴𝘵𝘳𝘶𝘤𝘵𝘶𝘳𝘦. 𝘈𝘤𝘤𝘰𝘳𝘥𝘪𝘯𝘨 𝘵𝘰 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯, 𝘵𝘩𝘦𝘳𝘦 𝘢𝘳𝘦 𝘢𝘵 𝘭𝘦𝘢𝘴𝘵 𝘧𝘰𝘶𝘳 𝘞𝘢𝘴𝘩𝘪𝘯𝘨𝘵𝘰𝘯-𝘤𝘰𝘯𝘵𝘳𝘰𝘭𝘭𝘦𝘥 𝘣𝘪𝘰𝘭𝘢𝘣𝘰𝘳𝘢𝘵𝘰𝘳𝘪𝘦𝘴 𝘰𝘱𝘦𝘳𝘢𝘵𝘪𝘯𝘨 𝘪𝘯 𝘕𝘪𝘨𝘦𝘳𝘪𝘢.

On August 29, 2005, the Ministry of Health of Ukraine and the Pentagon signed the "Treaty on Countering the Threat of Bioterrorism and Preventing the Spread of Bacteriological Weapons, Technology, Materials and Knowledge."

One of the Pentagon laboratories is located in Kharkiv, where in January 2016 at least 20 Ukrainian soldiers died from Flu-like virus in just two days with 200 more being hospitalized. The Ukrainian government did not report on the dead Ukrainian soldiers in Kharkiv. As of March 2016, 364 deaths have been reported across Ukraine (81.3 % caused by Swine Flu A (H1N1) pdm09 – the same strain which caused the world pandemic in 2009).

Metabiota, a company financed by Hunter Biden's Rosemont Seneca partnership with the CCP, receives the lion's share of Defense Department funding for its Ukrainian bio labs.

A highly suspicious Hepatitis A infection spread rapidly in just few months across South East Ukraine where most of the Pentagon biolabs are located. 37 people were hospitalized for Hepatitis A in the Ukrainian city of Mykolaiv as of January 2018. Local police launched an investigation into “infection with human immunodeficiency virus and other incurable diseases”. In addition, in 2016 more than 100 people in the same city became infected with Cholera. Both diseases are alleged to have spread through contaminated drinking water. In the summer of 2017, 60 people with Hepatitis A were admitted to hospital in the city of Zaporizhia, the cause of this outbreak is still unknown. In the Odessa region, 19 children from an orphanage were hospitalized for hepatitis A in June 2017. 29 cases of Hepatitis A were reported in Kharkiv in November 2017. The virus was isolated in contaminated drinking water. One of the Pentagon bio-labs is located in Kharkiv which was blamed for the deadly Flu outbreak in 2018 which claimed the lives of 364 Ukrainians.

In 2011 Ukraine was hit by a cholera outbreak. 33 patients were reportedly hospitalized for severe diarrhea. A second outbreak struck the country in 2014 when more than 800 people all across Ukraine were reported to have contracted the disease.

In 2015 at least 100 new cases were registered in the city of Mykolaiv alone. A new highly virulent variant of the cholera agent Vibrio cholera, with a high genetic similarity to the strains reported in Ukraine, hit Moscow in 2014. According to a 2014 Russian Research Anti-Plaque Institute genetic study the cholera strain isolated in Moscow was similar to the bacteria which caused the epidemic in neighboring Ukraine. Southern Research Institute, one of the US contractors working at the bio-laboratories in Ukraine, has projects on Cholera, as well as on Influenza and Zika – all pathogens of military importance to the Pentagon.

A now deleted article originally posted on June 18, 2020 which has been recovered entitled Biolab Opens in Ukraine details how Barack Obama, while serving as an Illinois Senator, helped negotiate a deal to build a level-3 bio-safety lab in the Ukrainian city of Odessa.

Metabiota, a company financed by Hunter Biden's Rosemont Seneca partnership with the Communist Party of China and the Peoples Republic of China's Peoples Liberation Army, was awarded a $18.4 million federal contract under the DTRA program in Georgia and Ukraine.

Ukrainian Science and Technology Centre

Among the set of bilateral agreements between the US and Ukraine is the establishment of the Science and Technology Center in Ukraine (STCU) – an International organization funded mainly by the US government which has been accorded diplomatic status. The US personnel in Ukraine work under diplomatic cover. The STCU officially supports projects of scientists previously involved in the Soviet biological weapons program. Over the past 20 years the STCU has invested over $285 million in funding and managing some 1,850 projects of scientists who previously worked on the development of weapons of mass destruction.

According to captured documents by the Russian Ministry of Defense, the Ukrainian Science and Technology Centre (STCU),

"is headquartered in Kiev and has regional offices in Baku, Chisinau and Tbilisi, as well as in Kharkov and Lvov. However, the Russian Ministry of Defence's Chemical and Biological Threat Expertise Centre found that the STCU's main activity is to act as a distribution centre for grants for research of interest to the Pentagon, including biological weapons research. In recent years alone, Washington has spent more than $350 million on STCU projects. The U.S. customers and sponsors of STCU are the Department of State and the Department of Defense. Funding is also provided through the Environmental Protection Agency, the US Departments of Agriculture, Health and Energy.... Between 2014 and 2022, the Ukrainian Science and Technology Centre implemented five hundred R&D projects in post-Soviet countries (Ukraine, Georgia, Moldova and Azerbaijan). US supervisors were primarily interested in dual-use research, such as project 6166, Development of Technologies for Modelling, Evaluation and Prediction of Effects of Conflicts and Threats of Mass Destruction Weapons Spread, and project 9601, Transfer of Ukrainian Technologies for the Production of Complex Dual-Use Materials to the European Union. Many of them are aimed at studying potential biological weapons agents (plague, tularaemia) and pathogens of economic importance (pathogenic avian influenza, African swine fever). Projects P-364, 444, and 781, aimed at studying the spread of dangerous pathogens through insect vectors, wild birds, and bats, were funded by the Centre directly in the interests of the military department. Note the documents of Project 3007 "Monitoring of the epidemiological and environmental situation regarding hazardous diseases of aquatic origin in Ukraine". During the work, Ukrainian specialists, supervised by American scientists, systematically collected water samples in a number of major Ukrainian rivers, including the Dnepr, Danube and Dniester, as well as in the North Crimean Canal, to determine the presence of particularly dangerous pathogens, including cholera, typhoid, hepatitis A and E pathogens, and draw conclusions about their possible waterborne spread. The project assessed the damage properties of the selected samples and deposited the strains in a collection and subsequently exported them to the USA. ...the results of this work can be used to create an unfavourable biological situation not only in the Russian Federation, but also in the Black Sea and the Sea of Azov, as well as in Eastern Europe - Belarus, Moldova and Poland.... Thus, during the special operation in Ukraine, it was established that US scientists from a laboratory in Merefa (Kharkov Region) were testing potentially dangerous biological drugs on patients of the regional clinical psychiatric hospital No 3 in Kharkov between 2019 and 2021. Persons with mental disorders were selected for the experiments on the basis of their age, nationality and immune status. Special forms were used to record the results of 24-hour patient monitoring. The information was not entered into the hospital database and the staff of the medical institution signed a non-disclosure agreement. In January 2022, the laboratory in Merefa was shut down and all equipment and preparations were moved to western Ukraine."

Peoples Republic of China

Wuhan Institute of Virology

From 2014 to 2019, $826,277 was given to the Wuhan Institute of Virology for bat coronavirus research by the National Institute of Allergy and Infectious Diseases (NIAID), which was headed by Dr. Anthony Fauci. In an April 15, 2020 email marked “high” importance, Principal Deputy Director of NIH Lawrence Tabak emailed Fauci, NIH Director Francis Collins, and other NIH officials with the subject line: “HEADS UP: Wuhan lab research.” Tabak provides details of the grant to Peter Daszak, president of EcoHealth Alliance, for a project titled “Understanding the Risk of Bat Coronavirus Emergence.” Tabak continues, saying, “The 3.7M dollar figure is over 6 years to all sites which include (several in) China, Thailand, Cambodia, Laos, Vietnam, Malaysia, Indonesia and Myanmar. We estimate that approximately $826,300 has been spent at this site since the inception of the grant. Yearly costs appear to be about 80K/year. The grant is in year 6 of a total of 10 year.”

Left:Shi Zhengli; Right:Ralph Baric.

A January 9, 2020, email exchange labeled “high” importance between NIAID Senior Scientific Advisor Dr. David Morens and Daszak details the relationship between the Fauci agency and the Wuhan Institute of Virology.

On January 23, 2020, the day the Wuhan viral outbreak was announced to the world, a senior NIH official, Melinda Hoskins, forwarded a Daily Mail article to colleagues discussing NIH/NIAID funding of the bat virus research, and noting that Fauci would be briefing senators the following morning. Hoskins says, “Would you please confirm the exact nature of our support to the Wuhan Institute of Virology/Biosafety Lab.”

On October 1, 2017, after receiving Daszak’s email related to his then-unpublished paper describing detailed research into a novel bat-born virus tied to Swine Acute Diarrheal Syndrome, Fauci forwards Daszak’s email and paper on to NIH official Greg Folkers, saying, “Confidential, but fyi for you.” Daszak says, “You should know that this work was supported by a NIAID ROl that [NIH’s] Erik Stemmy is the Program Officer for, and that I’m PI [principal investigator] on, with Zhengli Shi [the director of the Center for Emerging Infectious Diseases of the Wuhan Institute of Virology] as co-PI.”